Dark

AUPH
Aurinia Pharmaceuticals Inc
stock NASDAQ

At Close

Dec 29, 2025 3:59:59 PM EST

15.88USD-2.277%(-0.37)680,029

0.00Bid 0.00Ask 0.00Spread

Pre-market

Dec 29, 2025 8:02:30 AM EST

16.05USD-1.201%(-0.20)169

After-hours

Dec 29, 2025 4:00:30 PM EST

15.89USD+0.063%(+0.01)1,041

OverviewOptionsHistoricalExchangesShortsNews

Jan 28, 2022

10:01AM EST Hearing Dealreporter Reports Aurinia Pharma Said To Be On Biogen's Takeover Radar Benzinga

Jan 19, 2022

02:38PM EST Aurinia Pharmaceuticals Option Alert: Apr 14 $18 Puts Sweep (20) below Bid!: 222 @ $3.408 vs 659 OI; Earnings 2/23 After Close [est] Ref=$18.62 Benzinga

Jan 4, 2022

04:17PM EST Aurinia Pharmaceuticals to Present at Upcoming January Investor Conferences Business Wire

Dec 31, 2021

02:22PM EST Aurinia Pharmaceuticals Option Alert: Apr 14 $25 Calls Sweep (3) near the Ask: 201 @ $5.0 vs 7599 OI; Earnings 2/23 After Close [est] Ref=$23.91 Benzinga

Dec 29, 2021

10:49AM EST Shares of biopharmaceutical company Aurinia Pharmaceuticals Inc. (AUPH) are down 3 percent on Wednesday's trading despite there being no company news to impact the stock. RTTNews

Dec 23, 2021

10:31AM EST Aurinia Pharmaceuticals Option Alert: Jan 21 $30 Calls Sweep (19) near the Ask: 206 @ $1.5 vs 29005 OI; Ref=$22.99 Benzinga

Dec 10, 2021

01:23PM EST Expert Ratings For Aurinia Pharmaceuticals Benzinga

12:41PM EST Benzinga's Top Ratings Upgrades, Downgrades For December 10, 2021 Benzinga

06:51AM EST Oppenheimer Upgrades Aurinia Pharmaceuticals to Outperform, Lowers Price Target to $31 Benzinga

Dec 9, 2021

09:46PM EST The Daily Biotech Pulse: Reata Plunges On Adcom Snub, AstraZeneca Antibody Cocktail Authorized For COVID-19 Prevention, NeuroSense IPO Benzinga

09:45PM EST Aurinia Announces Topline Results From the AURORA 2 Continuation Study of LUPKYNIS (voclosporin) for the Treatment of Adults With Active Lupus Nephritis (LN) Show Sustained Meaningful Reductions in Proteinuria Compared to Mycophenolate Mofetil (Mmf) and Low-dose Oral Corticosteroids Alone, the Active Study Control Benzinga

06:27AM EST Aurinia Announces Positive Topline Results From AURORA 2 Continuation Study Of LUPKYNIS For Active Lupus Nephritis RTTNews

06:15AM EST Aurinia Announces Positive Topline Results From the AURORA 2 Continuation Study of LUPKYNIS(tm) (voclosporin) for the Treatment of Adults With Active Lupus Nephritis (LN) Business Wire

Nov 22, 2021

02:49PM EST Mid-Afternoon Market Update: Dow Rises 200 Points; Niu Technologies Shares Slide Benzinga

12:11PM EST Mid-Day Market Update: Gold Down 2%; iSpecimen Shares Spike Higher Benzinga

10:34AM EST Aurinia Pharmaceuticals Inc. (AUPH) shares are sliding more than 25 percent from the previous close, continuing a bearish trend in search of new support, after the company peaked to a five-year high by end of October. There were no corporate announcements on the day to impact the stock movement. RTTNews

10:19AM EST Mid-Morning Market Update: Markets Open Higher; Avaya Tops Q4 Views Benzinga

09:36AM EST Biotech Reporter Adam Feuerstein Tweets '$AUPH didn't just file a mixed shelf on Friday, it also entered into a $250M ATM stock sale agreement with Cantor Fitzgerald. The buyout speculation looks well past its expiration date.' Benzinga

Nov 10, 2021

04:05PM EST Aurinia Pharmaceuticals to Present at the 2021 Jefferies London Healthcare Conference Business Wire

Nov 9, 2021

12:16PM EST Aurinia Pharmaceuticals Option Alert: Dec 17 $35 Calls Sweep (12) near the Ask: 300 @ $3.2 vs 4290 OI; Ref=$30.29 Benzinga

Nov 5, 2021

12:54PM EDT Aurinia Pharmaceuticals Option Alert: Nov 19 $30 Calls at the Ask: 500 @ $4.45 vs 8392 OI; Ref=$32.96 Benzinga

09:27AM EDT What 5 Analyst Ratings Have To Say About Aurinia Pharmaceuticals Benzinga

Nov 4, 2021

10:00AM EDT Oppenheimer Maintains Perform on Aurinia Pharmaceuticals, Raises Price Target to $33 Benzinga

06:22AM EDT HC Wainwright & Co. Maintains Buy on Aurinia Pharmaceuticals, Raises Price Target to $40 Benzinga

04:50AM EDT SVB Leerink Maintains Outperform on Aurinia Pharmaceuticals, Raises Price Target to $35 Benzinga

Nov 3, 2021

11:13AM EDT Aurinia Pharmaceuticals shares were trading lower after the company reported worse-than-expected Q3 EPS results. Benzinga

09:18AM EDT Aurinia Pharmaceuticals: Q3 Earnings Insights Benzinga

09:12AM EDT Aurinia Pharmaceuticals Q3 EPS $(0.39) Misses $(0.33) Estimate, Sales $14.70M Beat $13.88M Estimate Benzinga

09:10AM EDT Earnings Scheduled For November 3, 2021 Benzinga

06:00AM EDT Aurinia Reports Third Quarter and Nine Months 2021 Financial Results and Company Updates Business Wire

Nov 1, 2021

10:26AM EDT Aurinia:reductions In Proteinuria Sustained With No Impact On Renal Function At 30 Months Of Treatment With Voclosporin RTTNews

10:12AM EDT Aurinia Pharma Offers Updated Interim Results From AURORA 2 Continuation Study Of LUPYNIS For Treatment Of Lupus Nephritis Benzinga

10:12AM EDT Aurinia Announces Updated Interim Results from the AURORA 2 Continuation Study of LUPKYNIS (voclosporin) for the Treatment of Lupus Nephritis Business Wire

Oct 29, 2021

12:36PM EDT Aurinia Pharmaceuticals Option Alert: Jan 21 $40 Calls at the Ask: 120 @ $2.6 vs 7904 OI; Earnings 11/3 Before Open Ref=$31.53 Benzinga

12:17PM EDT Aurinia Pharmaceuticals Option Alert: Nov 19 $35 Calls Sweep (3) near the Ask: 123 @ $2.951 vs 18128 OI; Earnings 11/3 Before Open Ref=$31.5 Benzinga

Oct 28, 2021

10:48AM EDT Benzinga's Top Ratings Upgrades, Downgrades For October 28, 2021 Benzinga

06:59AM EDT Oppenheimer Downgrades Aurinia Pharmaceuticals to Perform, Raises Price Target to $32 Benzinga

Oct 27, 2021

07:07AM EDT Aurinia Pharmaceuticals to Release Third Quarter 2021 Financial Results on November 3, 2021 Business Wire

Oct 26, 2021

04:10PM EDT Aurinia Pharmaceuticals to Present Five Abstracts at ASN Kidney Week 2021 and ACR Convergence 2021 Business Wire

07:12AM EDT RBC Capital Maintains Outperform on Aurinia Pharmaceuticals, Raises Price Target to $34 Benzinga

Oct 22, 2021

03:51PM EDT 'Bristol-Myers Said To Make Takeover Approach To Aurinia'- Bloomberg Benzinga

Oct 20, 2021

10:14AM EDT Aurinia Pharmaceuticals Option Alert: Nov 19 $20 Calls Sweep (15) near the Ask: 179 @ $2.45 vs 3882 OI; Earnings 11/9 After Close [est] Ref=$20.1 Benzinga

Oct 5, 2021

11:59AM EDT Aurinia Pharmaceuticals Option Alert: Oct 15 $23 Calls Sweep (22) near the Ask: 330 @ $0.95 vs 7433 OI; Earnings 11/9 After Close [est] Ref=$21.18 Benzinga

Sep 22, 2021

07:45AM EDT The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs Benzinga

Sep 21, 2021

12:36PM EDT Aurinia Pharmaceuticals Option Alert: Jan 21 $30 Calls at the Ask: 200 @ $3.3 vs 2977 OI; Earnings 11/9 After Close [est] Ref=$23.12 Benzinga

Sep 15, 2021

01:11PM EDT Aurinia Pharmaceuticals to Present at Upcoming September Investor Conferences Business Wire

07:38AM EDT The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs Benzinga

Sep 14, 2021

07:50AM EDT The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout Benzinga

Sep 10, 2021

01:30PM EDT Aurinia Pharmaceuticals to Participate in H.C. Wainwright 23rd Annual Global Investment Conference Business Wire

Sep 8, 2021

02:22PM EDT Aurinia Pharmaceuticals Option Alert: Sep 17 $15 Calls Sweep (10) near the Ask: 111 @ $3.8 vs 5369 OI; Ref=$18.63 Benzinga

02:14PM EDT Aurinia Pharmaceuticals Option Alert: Sep 17 $17 Calls Sweep (23) near the Ask: 220 @ $2.201 vs 5997 OI; Ref=$18.61 Benzinga

Aug 26, 2021

10:11AM EDT Aurinia Pharma Spokesperson Tells Benzinga Information Given In Press Release at 9:35 a.m. EDT Thursday Is Fraudulent Information Not Issued, Created By The Co., Should Be Removed Benzinga

10:06AM EDT Aurinia Pharma Shares Up 3.7% Following Earlier Press Release From Co. Disclosing It Entered Deal To Be Acquired By Unnamed 'Pharma Behemoth' At $35+/ADS Benzinga

Aug 17, 2021

10:35AM EDT Shares of Aurinia Pharmaceuticals Inc. (AUPH) are down more than 9% Tuesday morning after the company said it acquired two pipeline assets proposed for autoimmune and kidney related diseases. RTTNews

06:39AM EDT Aurinia Adds Two Assets To Expand Its Immunology Pipeline Benzinga

06:09AM EDT Aurinia Acquires Novel Pipeline Assets Targeting Autoimmune And Kidney-related Diseases RTTNews

06:08AM EDT Aurinia Pharmaceuticals Acquires Pipeline Assets Targeting Autoimmune And Kidney-related Diseases; Acquires AUR200For $750K Upfront Plus Potential Milestones, Acquires AUR300 From Riptide For $6M Plus Future Milestones Benzinga

06:05AM EDT Aurinia Acquires Novel Pipeline Assets Targeting Autoimmune and Kidney-related Diseases Business Wire

Aug 9, 2021

07:55AM EDT Aurinia Pharmaceuticals to Present at the BTIG Virtual Biotech Conference Business Wire

Aug 6, 2021

02:40PM EDT Mid-Afternoon Market Update: Dow Gains 140 Points; Spectrum Pharmaceuticals Shares Plummet Benzinga

12:11PM EDT Mid-Day Market Update: Gold Drops 2.5%; Sphere 3D Shares Spike Higher Benzinga

07:42AM EDT The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO Benzinga

Aug 5, 2021

05:27PM EDT Aurinia Pharmaceuticals Q2 EPS $(0.37) Misses $(0.14) Estimate, Sales $6.62M Up From $29.00K YoY Benzinga

04:06PM EDT Aurinia Reports Second Quarter and Six Months 2021 Financial Results and Recent Operational Highlights Business Wire

04:08AM EDT Earnings Scheduled For August 5, 2021 Benzinga

Aug 4, 2021

07:45AM EDT Cramer Advises Viewers On Palantir, SoFi And More Benzinga

Jul 29, 2021

03:58PM EDT Aurinia Pharmaceuticals Option Alert: Sep 17 $19 Calls Sweep (12) near the Ask: 247 @ $1.051 vs 67 OI; Earnings 8/5 After Close Ref=$13.95 Benzinga

Jul 27, 2021

11:13AM EDT Aurinia Pharmaceuticals Wins U.S. Government Contract From Department Of Veterans Affairs Benzinga

Jul 26, 2021

06:05AM EDT Aurinia Pharmaceuticals to Release Second Quarter 2021 Financial Results on August 5, 2021 Business Wire

Jul 20, 2021

10:23AM EDT Aurinia Pharma Sam.Gov Contract Listing For $1.027M Contract With Dept. Of Veterans Affairs Benzinga

Jul 16, 2021

05:30PM EDT Aurinia Pharmaceuticals Announces Delisting from the Toronto Stock Exchange Business Wire

Jun 30, 2021

07:05AM EDT Aurinia Awards $250,000 in Grants to Support Patient Navigation Programs Business Wire

Jun 25, 2021

05:34AM EDT Aurinia Pharmaceuticals Announced Licensing Partner Otsuka Filed Initial Marketing Authorization Application for Voclosporin with the European Medicines Agency Benzinga

05:14AM EDT Aurinia Announces Licensing Partner Otsuka Filed Initial Marketing Authorization Application (MAA) for Voclosporin with the European Medicines Agency (EMA) Business Wire

Jun 7, 2021

07:05PM EDT Aurinia Announces Results of the 2021 Annual General Meeting Business Wire

07:25AM EDT Aurinia Announces Additional Analysis Of AURORA 1 Phase 3 Study Data Presented At ERA-EDTA 2021 Congress RTTNews

07:05AM EDT Aurinia Announces Additional Analysis of its AURORA 1 Phase 3 Study Data Presented at ERA-EDTA 2021 Congress Benzinga

Jun 2, 2021

08:20AM EDT The Daily Biotech Pulse: FDA Nod For Novartis, iRhythm CEO Quits Abruptly, Moderna Inks Vaccine Supply Agreements Benzinga

May 27, 2021

06:05AM EDT Aurinia Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference Business Wire

May 21, 2021

07:58AM EDT Aurinia's Lupkynis Shows Sustained Renal Response Rates In Lupus Nephritis Patients Benzinga

May 20, 2021

04:13PM EDT Aurinia Pharma Reports Will Present Supportive AURORA 2 Continuation Study Interim Analysis Demonstrating Long-Term Safety & Efficacy of LUPKYNIS (voclosporin) in Subjects with Lupus Nephritis Benzinga

04:05PM EDT Aurinia To Present Supportive AURORA 2 Continuation Study Interim Analysis Demonstrating Long-Term Safety & Efficacy of LUPKYNIS(tm) (voclosporin) in Subjects with Lupus Nephritis Business Wire

May 14, 2021

06:05AM EDT Aurinia Pharmaceuticals to Participate in Two Upcoming Investor Conferences Business Wire

May 12, 2021

08:57AM EDT The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron Benzinga

May 11, 2021

07:54AM EDT The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings Benzinga

May 10, 2021

04:06PM EDT Aurinia Unveils Patient Navigation Grant Program to Address Access Barriers for Individuals Living with Lupus and Lupus Nephritis Business Wire

06:57AM EDT Aurinia Announces Publication Of AURORA 1 Phase 3 Study Results With LUPKYNIS In The Lancet RTTNews

06:53AM EDT Aurinia Pharma's Stock Gains After Lupkynis Data From Late-Stage Lupus Nephritis Study Published In Lancet Benzinga

06:10AM EDT Aurinia Announced Publication of AURORA 1 Phase 3 Study Results with LUPKYNIS in The Lancet; Study Showed Statistically Superior Complete Renal Response Rates at 52 Weeks Compared to Treatment With Mmf and Low-dose Corticosteroids Alone Benzinga

06:05AM EDT Aurinia Announces Publication of AURORA 1 Phase 3 Study Results with LUPKYNIS(tm) (voclosporin) in The Lancet Business Wire

May 7, 2021

11:00AM EDT Cramer Shares His Thoughts On Atkore, Petco And More Benzinga

07:40AM EDT The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs Benzinga

May 6, 2021

05:14PM EDT Aurinia Pharmaceuticals Q1 EPS $(0.40) Down From $(0.23) YoY, Sales $914.00K Up From $30.00K YoY Benzinga

04:07PM EDT Aurinia Reports First Quarter 2021 Financial Results and Recent Operational Highlights Business Wire

07:49AM EDT The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom Benzinga

04:17AM EDT Earnings Scheduled For May 6, 2021 Benzinga

Apr 28, 2021

06:30AM EDT Aurinia Pharmaceuticals to Release First Quarter 2021 Financial Results on May 6, 2021 Business Wire

Apr 21, 2021

07:31AM EDT The Daily Biotech Pulse: Moderna To Supply Variant-Specific Vaccine To Israel, Roche's Diagnostics Business Comes to Rescue Benzinga

Apr 20, 2021

08:07AM EDT The Daily Biotech Pulse: Q1 Beat From Johnson & Johnson, KalVista Study Placed On Hold, European Label Expansion For GW Pharma's Epidiolex Benzinga

Apr 15, 2021

06:05AM EDT Aurinia Pharmaceuticals to Present at the Bloom Burton & Co. Healthcare Investor Conference Business Wire

Apr 8, 2021

08:14AM EDT The Daily Biotech Pulse: Immutep Extends Run, FDA Nod For Gilead, Merck, Bristol-Myers Squibb Release Late-Stage Cancer Immunotherapy Data Benzinga

07:38AM EDT Aurinia's Lupkynis Shows Treatment Benefit In Lupus Nephritis, Additional Efficacy Data Shows Benzinga

06:09AM EDT Aurinia Presents Data Demonstrating LUPKYNIS Efficacy Across Lupus Nephritis Biopsy Classes at National Kidney Foundation 2021 Spring Clinical Meetings Benzinga

06:09AM EDT Aurinia Pharma Presents Addl Efficacy Data From AURA-LV And AURORA 1 Pivotal Trials Of LUPKYNIS In Lupus Nephritis RTTNews

06:05AM EDT Aurinia Presents Data Demonstrating LUPKYNIS(tm) (voclosporin) Efficacy Across Lupus Nephritis Biopsy Classes at National Kidney Foundation 2021 Spring Clinical Meetings Business Wire

Mar 15, 2021

06:16AM EDT Aurinia Announces Positive Cost-Effectiveness Assessment Of LUPKYNIS In Latest ICER Draft Evidence Report RTTNews

06:05AM EDT Aurinia Announces Positive Cost-Effectiveness Assessment of LUPKYNIS(tm) (voclosporin) in Latest ICER Draft Evidence Report Business Wire

Mar 2, 2021

06:05AM EST Aurinia Pharmaceuticals to Present at Three Upcoming March Investor Conferences Business Wire

Feb 24, 2021

04:19PM EST Aurinia Pharmaceuticals Q4 EPS $(0.05) Beats $(0.14) Estimate, Sales $50.00M Beat $40.00K Estimate Benzinga

04:02PM EST Aurinia Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Operational Highlights Business Wire

09:45AM EST The Food and Drug Administration approved four new drugs last month. In the year 2020, 104 new drugs were approved by the FDA. Now, let us take a look at the new drugs approved by the regulator in January 2021. RTTNews

03:35AM EST Earnings Scheduled For February 24, 2021 Benzinga

Feb 23, 2021

01:00PM EST The Food and Drug Administration approved four new drugs last month. In the year 2020, 104 new drugs were approved by the FDA. Now, let us take a look at the new drugs approved by the regulator in January 2021. RTTNews

10:29AM EST Earnings Preview: Aurinia Pharmaceuticals Benzinga

Feb 22, 2021

01:32AM EST The Food and Drug Administration approved four new drugs last month. In the year 2020, 104 new drugs were approved by the FDA. Now, let us take a look at the new drugs approved by the regulator in January 2021. RTTNews

Feb 18, 2021

06:05AM EST Aurinia Pharmaceuticals to Present at the SVB Leerink 10th Annual Global Healthcare Conference Business Wire

Feb 17, 2021

06:05AM EST Aurinia Pharmaceuticals to Release Fourth Quarter and Year End 2020 Financial Results on February 24, 2021 Business Wire

Jan 31, 2021

05:22AM EST Attention Biotech Investors: Mark Your Calendar For February PDUFA Dates Benzinga

Jan 27, 2021

05:26AM EST SVB Leerink Maintains Outperform on Aurinia Pharmaceuticals, Raises Price Target to $28 Benzinga

Jan 26, 2021

08:07AM EST The Daily Biotech Pulse: Novartis Misses, J&J Beats In Big Pharma Earnings, Vaccine Developer CureVac Taps Equity Market Benzinga

Jan 25, 2021

08:22AM EST 10 Biggest Price Target Changes For Monday Benzinga

06:17AM EST HC Wainwright & Co. Maintains Buy on Aurinia Pharmaceuticals, Raises Price Target to $35 Benzinga

Jan 23, 2021

09:14AM EST The Week Ahead In Biotech (Jan 24-30): J&J, Lilly to Kickstart Big Pharma Earnings, Amgen FDA Decision and More Benzinga

Jan 22, 2021

08:24PM EST FDA Approves Aurinia Pharmaceuticals' LUPKYNIS(tm) (voclosporin) for Adult Patients with Active Lupus Nephritis Business Wire

07:22AM EST The Daily Biotech Pulse: Fluidigm's Saliva-Based COVID Test Approved In Europe, China Backs Amarin's Vascepa Benzinga

Jan 8, 2021

06:05AM EST Aurinia Pharmaceuticals to Present at Two Upcoming Virtual Healthcare Conferences Business Wire

Jan 2, 2021

10:46AM EST Attention Biotech Investors: Mark Your Calendar For January PDUFA Dates Benzinga

Dec 17, 2020

02:22PM EST Why Aurinia's Stock Is Trading Lower Today Benzinga

02:12PM EST Aurinia Pharmaceuticals Shares Down 13% For Session; Co Yesterday Evening Announced In SEC Filing That Co, Lonza Enter Exclusive Agreement For Dedicated Voclosporin Manufacturing Capacity; Says Monoplant Estimated To Be Operational In 2023 Benzinga

08:10AM EST The Daily Biotech Pulse: MacroGenics Breast Cancer Drug Wins FDA Approval, Adcom Test Awaits Moderna, Virios To Make Wall Street Debut Benzinga

04:04AM EST Aurinia Announces Collaboration Deal With Otsuka Pharma For Development Of Voclosporin In Europe And Japan RTTNews

04:00AM EST Aurinia Announces Collaboration and Licensing Agreement with Otsuka Pharmaceutical Co., Ltd. for the Development and Commercialization of Voclosporin in Europe and Japan Business Wire

Dec 16, 2020

07:15AM EST The Daily Biotech Pulse: Novartis Gets Adcom Backing, Sio Gene Data, 2 IPOs, BioNTech Clinches China Vaccine Supply Deal Benzinga

Dec 15, 2020

06:00PM EST Aurinia and Lonza Announce Exclusive Agreement for Dedicated Voclosporin Manufacturing Capacity Benzinga

Dec 2, 2020

06:05AM EST Aurinia Pharmaceuticals to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference Business Wire

Nov 20, 2020

05:00PM EST Aurinia Announces New Employment Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Business Wire

Nov 12, 2020

04:05PM EST Aurinia Pharmaceuticals to Present at the 2020 Jefferies Virtual London Healthcare Conference Business Wire

Nov 10, 2020

04:30PM EST Aurinia Pharmaceuticals: Q3 Earnings Insights Benzinga

04:09PM EST Aurinia Pharmaceuticals Q3 EPS $(0.28) Misses $(0.15) Estimate, Sales $29.00K Miss $50.00K Estimate Benzinga

04:02PM EST Aurinia Reports Third Quarter 2020 Financial Results and Recent Operational Highlights Business Wire

Nov 9, 2020

04:37PM EST Aurinia Pharma Highlights Presentation Of Integrated Time To Renal Response Data From AURA-LV, AURORA Trials, Voclosporin Data At American College Of Rheumatology Meeting Benzinga

04:06PM EST Aurinia Presents Integrated Time to Renal Response Data from the AURA-LV and AURORA Trials, along with Voclosporin Drug-Drug Interaction Data at ACR Convergence 2020 Business Wire

Nov 3, 2020

04:58PM EST Why Aurinia Pharmaceuticals Stock Is Trading Lower Today Benzinga

10:28AM EST Stocktwits Trending Stocks For Tuesday, Nov. 3, 2020: BABA, W, BHC, JD, AUPH, PYPL, CPE, SEDG, TLRY, PLUG Benzinga

07:38AM EST The Daily Biotech Pulse: Aurinia Pulls The Plug On Dry Eye Disease Study, Karyopharm's Positive Readout, Emergency Use Authorization For OraSure Benzinga

06:44AM EST HC Wainwright & Co. Maintains Buy on Aurinia Pharmaceuticals, Lowers Price Target to $28 Benzinga

Nov 2, 2020

04:15PM EST Aurinia Pharma Reports AUDREY Trial In Dry Eye Syndrome Did Not Achieve Statistical Significance On Primary Endpoint; Co. Will Suspend Development Program For Voclosporin Ophthalmic Solution Benzinga

04:06PM EST Aurinia Announces Outcome of AUDREY(tm) Clinical Trial in Dry Eye Syndrome Business Wire

Oct 27, 2020

04:14PM EDT Aurinia Announces European Investigator-Initiated Trial To Evaluate Antiviral Activity Of Voclosporin In Kidney Transplant Recipients With COVID-19 Benzinga

Oct 22, 2020

04:18PM EDT Aurinia Presents Voclosporin Efficacy And Pharmacokinetic Data From Integrated Analysis Of AURA-LV And AURORA Pivotal Trials At ASN Kidney Week 2020 Benzinga

Oct 14, 2020

06:05AM EDT Aurinia Pharmaceuticals Announces Launch of Lupus Nephritis Disease-State Awareness Initiative for Healthcare Professionals, TimeIsNephrons.com Business Wire

Oct 2, 2020

05:00PM EDT Aurinia Announces New Employment Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire

Sep 28, 2020

06:10AM EDT Aurinia Completes Final Patient Treatment In AUDREY Phase 2/3 Clinical Trial Of Voclosporin Ophthalmic Solution RTTNews

06:05AM EDT Aurinia Completes Final Patient Treatment in AUDREY Phase 2/3 Clinical Trial of Voclosporin Ophthalmic Solution for Dry Eye Syndrome Business Wire

Sep 4, 2020

06:04PM EDT Aurinia Announces New Employment Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire

Aug 12, 2020

11:23AM EDT HC Wainwright & Co. Maintains Buy on Aurinia Pharmaceuticals, Raises Price Target to $34 Benzinga

Aug 11, 2020

05:29PM EDT Recap: Aurinia Pharmaceuticals Q2 Earnings Benzinga

04:16PM EDT Aurinia Pharmaceuticals Q2 EPS $(0.26) Misses $(0.14) Estimate, Sales $29.00K Miss $40.00K Estimate Benzinga

04:02PM EDT Aurinia Reports Second Quarter 2020 Financial Results and Recent Operational Highlights Business Wire

04:02AM EDT Earnings Scheduled For August 11, 2020 Benzinga

Aug 4, 2020

06:05AM EDT Aurinia Pharmaceuticals to Present at the BTIG Virtual Biotechnology Conference Business Wire

Jul 30, 2020

06:05AM EDT Aurinia Pharmaceuticals to Report Second Quarter 2020 Financial Results on August 11, 2020 Business Wire

Jul 27, 2020

10:34AM EDT Aurinia Closes $200 Mln Public Offering Of Common Shares RTTNews

10:15AM EDT Aurinia Closes US$200 Million Public Offering of Common Shares Business Wire

Jul 23, 2020

03:15PM EDT Mid-Afternoon Market Update: Dow Tumbles 400 Points; Milestone Pharmaceuticals Shares Gain Benzinga

12:10PM EDT Mid-Day Market Update: Brightcove Surges On Upbeat Q2 Results; Aurinia Pharmaceuticals Shares Slide Benzinga

05:41AM EDT Aurinia Prices US$200 Million Public Offering of Common Shares Benzinga

Jul 22, 2020

11:11PM EDT Aurinia Pharma Announces Pricing Of Underwritten Public offering Of 13.33 Mln Shares At US$15.00/shr RTTNews

11:05PM EDT Aurinia Prices US$200 Million Public Offering of Common Shares Business Wire

04:08PM EDT Aurinia Announces Public Offering of Common Shares Business Wire

11:19AM EDT HC Wainwright & Co. Maintains Buy on Aurinia Pharmaceuticals, Raises Price Target to $33 Benzinga

10:31AM EDT Shares of Aurinia Pharmaceuticals Inc. (AUPH) are gaining about 11% on the Nasdaq. The other day, the U.S. Food and Drug Administration accepted the filing of the company's New Drug Application for voclosporin, a potential treatment for lupus nephritis. RTTNews

Jul 21, 2020

05:27PM EDT Aurinia Announces U.S. Food and Drug Administration Acceptance of the Filing of New Drug Application and Priority Review for Voclosporin for the Treatment of Lupus Nephritis Business Wire